| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/20/2001 | CA2403205A1 Compositions and methods of regulated protein expression in gut endocrine k cells |
| 09/20/2001 | CA2403120A1 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material |
| 09/20/2001 | CA2403113A1 Methods of improving homologous recombination |
| 09/20/2001 | CA2403000A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | CA2402940A1 G-protein coupled receptors |
| 09/20/2001 | CA2402912A1 Transgenic mice containing targeted gene disruptions |
| 09/20/2001 | CA2402877A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 09/20/2001 | CA2402772A1 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | CA2402729A1 Human immune response proteins |
| 09/20/2001 | CA2402721A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 09/20/2001 | CA2402639A1 L-leucyl-l-leucine methyl ester treatment of donor lypmhocyte infusions in hematopoietic stem cell transplant patients |
| 09/20/2001 | CA2402614A1 Insulin homolog polypeptide zins4 |
| 09/20/2001 | CA2402562A1 A process for the production of human interferon alpha from genetically engineered yeast |
| 09/20/2001 | CA2402265A1 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 09/20/2001 | CA2402248A1 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | CA2402245A1 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 09/20/2001 | CA2402237A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | CA2402147A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | CA2401448A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2401417A1 High fidelity reverse transcriptases and uses thereof |
| 09/20/2001 | CA2401406A1 Human olfactory receptors and genes encoding same |
| 09/20/2001 | CA2401273A1 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | CA2401270A1 Method for labeling individual cells |
| 09/20/2001 | CA2401252A1 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | CA2400825A1 Three-dimensional model of a fc region of an ige antibody and uses thereof |
| 09/20/2001 | CA2373414A1 A novel factor-h related protein 5 and antobodies thereto |
| 09/20/2001 | CA2373110A1 Production of chimeric capsid vectors |
| 09/19/2001 | EP1134286A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/19/2001 | EP1133698A1 Prion protein standard and method of making same |
| 09/19/2001 | EP1133691A2 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device |
| 09/19/2001 | EP1133575A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 09/19/2001 | EP1133572A2 Chlamydia pneumoniae genome sequence |
| 09/19/2001 | EP1133570A1 Organisms for the extracellular production of riboflavin |
| 09/19/2001 | EP1133569A1 Hiv vaccine |
| 09/19/2001 | EP1133568A2 Regulatory sequences useful for gene expression in plant embryo tissue |
| 09/19/2001 | EP1133565A2 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 09/19/2001 | EP1133564A1 Zace1: a human metalloenzyme |
| 09/19/2001 | EP1133563A2 Methods and molecules relating to cd39-like polypeptides |
| 09/19/2001 | EP1133561A2 Protein fragments for use in protein targeting |
| 09/19/2001 | EP1133560A1 Human parathyroid hormone modifications, preparation and use |
| 09/19/2001 | EP1133559A2 Human orphan g protein-coupled receptors |
| 09/19/2001 | EP1133558A1 Compositions and methods for increasing bone mineralization |
| 09/19/2001 | EP1133557A2 Growth factor modulators |
| 09/19/2001 | EP1133554A2 Polypeptides having choline oxidase activity and nucleic acids encoding same |
| 09/19/2001 | EP1133523A1 Generation of antibodies using polynucleotide vaccination in avian species |
| 09/19/2001 | EP1133520A2 Compositions and methods using lactadherin or variants thereof |
| 09/19/2001 | EP1133519A2 Functional antagonists of hedgehog activity |
| 09/19/2001 | EP1133516A1 Chromosome 17p-linked prostate cancer susceptibility gene |
| 09/19/2001 | EP1133515A1 Dna molecules encoding hg51, a g-protein-coupled receptor |
| 09/19/2001 | EP1133313A2 Calcitonin for the modulation of sperm function |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP1133294A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 09/19/2001 | EP1108212A4 Methods and materials for diagnosing unstable angina |
| 09/19/2001 | EP0928173A4 Compositions and methods for intervertebral disc reformation |
| 09/19/2001 | EP0876095A4 Electroporation-mediated molecular transfer in intact plants |
| 09/19/2001 | EP0593755B1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 09/19/2001 | CN1313951A Assay to indicate the presence of non-fertilisable ova |
| 09/19/2001 | CN1313902A DNA constructs comprising protease encoding sequences or inhitors thereof |
| 09/19/2001 | CN1313901A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 09/19/2001 | CN1313900A Novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 09/19/2001 | CN1313899A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 09/19/2001 | CN1313897A New gene of humanlysoenzyme, the encoding polypeptide and methods for preparing them |
| 09/19/2001 | CN1313773A Antigenic peptides derived from telomerase |
| 09/18/2001 | US6291743 Transgenic plants expressing mutant geminivirus AC1 or C1 genes |
| 09/18/2001 | US6291740 Transgenic animals |
| 09/18/2001 | US6291664 Method of eliminating inhibitory/instability regions of mRNA |
| 09/18/2001 | US6291661 flt3-L mutants and method of use |
| 09/18/2001 | US6291658 Isolated nucleic acid molecules encoding SSX family members and thereof |
| 09/18/2001 | US6291649 Anti-bodies binding adhesin-derived antigens |
| 09/18/2001 | US6291647 Antifungal proteins, DNA coding therefor, and hosts incorporating same |
| 09/18/2001 | US6291643 Apaf-1 an activator of caspase-3 |
| 09/18/2001 | US6291642 Mammalian cell cycle protein |
| 09/18/2001 | US6291516 Contacting the cell with a composition including at least one cyclic amp agonist. |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291244 Method of producing transformed cells of barley |
| 09/18/2001 | US6291243 Expression vectors for the insertion of genetic material into cells; for use in gene therapy |
| 09/18/2001 | US6291240 Cells or tissues with increased protein factors and methods of making and using same |
| 09/18/2001 | US6291238 Tranforming with expression vector of gene for yeast cytoplasmic pyruvate carboxylase and promoter for transcription control |
| 09/18/2001 | US6291226 Adenovirus mutants with deleted protease gene |
| 09/18/2001 | US6291225 Microorganismal material for use in the treatment, diagnosis and prevention of microorganismal infection |
| 09/18/2001 | US6291214 System for generating recombinant viruses |
| 09/18/2001 | US6291211 Expressing heterologous polypeptides in cells; incubate cells with expression vectors, transform cells, express heterologous polypeptide |
| 09/18/2001 | US6291210 Differentiation inhibitor |
| 09/18/2001 | US6291206 BMP receptor proteins |
| 09/18/2001 | US6291195 Generating ligands which bind preferential human receptors; incubate cells expressing preferential binding protein with modulator, detect adjustment in binding activity |
| 09/18/2001 | US6291194 Assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound |
| 09/18/2001 | US6291162 Determining amount of lactamase activity; transfecting cells with a nucleic acid having an expression control sequence linked to a secretion defective sequence; mixing cells with lactamase substrate; determine amount of cleaved substrate |
| 09/18/2001 | US6290972 Provides isolated human and murine cd40-l polypeptides that bind to the extracellular binding region of a cd40 receptor. |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | US6290954 Contacting a source suspected of containing native prpsc with a diagnostically effective amount of an antibody characterized by its ability to bind to native prpsc in situ; and determining whether the antibody binds to any material |
| 09/18/2001 | US6290951 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells |
| 09/18/2001 | CA2238879C Thereapeutic applications for the anti-t-bam (cd40-l) monoclonal antibody 5c8 |
| 09/18/2001 | CA2145182C Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 09/18/2001 | CA2023894C Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | WO2001066747A2 Proteins named fctrx and nucleic acids encoding same |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2401552A1 Proteins named fctrx and nucleic acids encoding same |
| 09/13/2001 | WO2001067110A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 09/13/2001 | WO2001067109A1 Method of identifying modulators of presenilin |